CEL-SCI

CVM40

Penny Stock

$1.07arrow_drop_down1.83%-$0.02

Penny Stock

CVM40

$1.07

arrow_drop_down1.83%-$0.02

Penny Stock

Performance History

Key Stats
Open	$1.07
Prev. Close	$1.06
EPS	-0.58
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$66.41M
PE Ratio	-

	LOW	HIGH
Day Range	1.06	1.10
52 Week Range	1.02	3.23

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.58

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About CEL-SCI (CVM)

CEL-SCI Corp (CVM) is a biotechnology company that focuses on the research and development of immunotherapy treatments for cancer and infectious diseases. The company's flagship product, Multikine, is a potential immunotherapy treatment for head and neck cancer. Multikine is currently in Phase 3 clinical trials and has shown promising results in earlier studies. CEL-SCI Corp is also developing other immunotherapy treatments, including its LEAPS technology for the treatment of rheumatoid arthritis and other autoimmune diseases.

The stock price history of CEL-SCI Corp has been volatile, with significant fluctuations over the years. Investors should be aware that biotech stocks, in general, tend to be more volatile than other sectors. As of the latest quote, the stock is trading at $XX.XX per share. The market cap of the company is $XXX.XX million, reflecting its position as a mid-cap stock. The 52-week range of the stock is $XX.XX to $XX.XX, indicating the range of prices at which the stock has traded over the past year.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO
Headquarters: Vienna
Employees: 0
Exchange: NYSE

Keep an eye on CEL-SCI

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is CEL-SCI's (CVM) price per share?

The current price per share for CEL-SCI (CVM) is $1.07. The stock has seen a price change of -$0.02 recently, indicating a -1.83% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for CEL-SCI (CVM)?

For CEL-SCI (CVM), the 52-week high is $3.23, which is 201.87% from the current price. The 52-week low is $1.02, the current price is 4.9% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is CEL-SCI (CVM) a growth stock?

CEL-SCI (CVM) has shown an average price growth of 0.41% over the past three years. It has received a score of 8 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying CEL-SCI as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is CEL-SCI (CVM) stock price performance year to date (YTD)?

As of the latest data, CEL-SCI (CVM) has a year-to-date price change of -60.22%. Over the past month, the stock has experienced a price change of -7.76%. Over the last three months, the change has been -16.41%. Over the past six months, the figure is -55.6%. Looking at a longer horizon, the five-year price change stands at -85.9%.

help

Is CEL-SCI (CVM) a profitable company?

CEL-SCI (CVM) has a net income of -$32.19M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$31.48M. Furthermore, the EBITDA is -$25.52M.

help

What is the market capitalization of CEL-SCI (CVM)?

CEL-SCI (CVM) has a market capitalization of $67.03M. The average daily trading volume is 215.22K, indicating the stock's liquidity and investor engagement.